APA (7th ed.) Citation

Huang, Z., Xu, L., Wu, Z., Xiong, X., Luo, L., Wen, Z., & Liu, H. (2024). CDC25B Is a Prognostic Biomarker Associated With Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma. International Journal of Genomics, 2024, 1. https://doi.org/10.1155/2024/8922878

Chicago Style (17th ed.) Citation

Huang, Zixiang, Liangzhi Xu, Zhengqiang Wu, Xiaofeng Xiong, Linfei Luo, Zhili Wen, and Hongda Liu. "CDC25B Is a Prognostic Biomarker Associated With Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma." International Journal of Genomics 2024 (2024): 1. https://doi.org/10.1155/2024/8922878.

MLA (9th ed.) Citation

Huang, Zixiang, et al. "CDC25B Is a Prognostic Biomarker Associated With Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma." International Journal of Genomics, vol. 2024, 2024, p. 1, https://doi.org/10.1155/2024/8922878.